CF Bankshares 10-Q: Q3 EPS $0.91 as Criticized Loans Double to $42.0M
CFBK sits 58% above its 52-week low of $22.1 on light trading volume (0.1× avg).
Summary
CF Bankshares' Q3 10-Q confirms $6.0 million of net income ($0.91 diluted EPS) already reported October 27, but details a doubling of criticized loans to $42.0 million and nonperforming loans up to $20.4 million. The CEO also adopted a new 10b5-1 plan for up to 70,000 shares.
Key Events · Earnings and Guidance · CFBK
-
Q3 Earnings Confirmed at $0.91 EPS
Net income of $6.0 million ($0.91 diluted) versus $2.3 million ($0.36) a year earlier, helped by provision expense falling to $551,000 from $5.1 million.
-
Criticized Loans Double in Nine Months
Criticized and classified loans rose $28.9 million, or 100.6%, with special mention up $23.5 million to $42.0 million and substandard up $5.8 million to $15.7 million.
-
Nonperforming Loans Rise to $20.4M
Nonperforming loans increased $5.1 million from $15.3 million at year-end, including a $5.0 million non-core syndicated C&I loan; the allowance covers 1.03% of loans.
-
CEO Adopts New 10b5-1 Plan
Timothy O'Dell terminated his May 13, 2026 plan on August 10, 2026 and adopted a new plan on September 8, 2026 for up to 70,000 shares through September 30, 2027.
Analysis · CFBK · Finance
The headline numbers were already out on October 27, but the full 10-Q shows the credit picture deteriorating faster than the earnings suggest. Criticized and classified loans jumped $28.9 million, or 100.6%, in nine months to $42.0 million of special mention plus $15.7 million substandard, and nonperforming loans climbed to $20.4 million from $15.3 million. Management notes two of the large past-due credits were brought current after quarter-end, which softens the read, but the allowance is only 1.03% of loans against a 1.10% nonperforming rate. Separately, CEO O'Dell replaced his trading plan in September with one covering up to 70,000 shares through September 2027 — a scheduled-sale overhang, not a sale that has happened.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CFBK was trading at $34.96 on NASDAQ in the Finance sector, with a market capitalization of approximately $236.6M. The 52-week trading range was $22.10 to $38.11. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.